(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202109 | 202009 | % Var | 202109 | 202009 | % Var | 202103 | 202003 | % Var | |
| Sales | 28.96 | 37.96 | -23.71 | 57.85 | 61.00 | -5.16 | 139.49 | 148.32 | -5.95 |
| Other Income | 0.50 | 0.37 | 35.14 | 0.88 | 0.41 | 114.63 | 3.14 | 1.63 | 92.64 |
| PBIDT | 2.28 | 2.42 | -5.79 | 4.45 | 4.13 | 7.75 | 12.32 | 9.26 | 33.05 |
| Interest | 0.12 | 0.06 | 100.00 | 0.17 | 0.12 | 41.67 | 0.32 | 0.35 | -8.57 |
| PBDT | 2.16 | 2.36 | -8.47 | 4.28 | 4.01 | 6.73 | 12.00 | 8.91 | 34.68 |
| Depreciation | 0.37 | 0.45 | -17.78 | 0.74 | 0.89 | -16.85 | 1.46 | 1.78 | -17.98 |
| PBT | 1.79 | 1.91 | -6.28 | 3.54 | 3.12 | 13.46 | 10.54 | 7.13 | 47.83 |
| TAX | 0.40 | 0.40 | 0.00 | 0.80 | 0.70 | 14.29 | 2.24 | 1.67 | 34.13 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.06 | -0.09 | -33.33 |
| PAT | 1.39 | 1.51 | -7.95 | 2.74 | 2.42 | 13.22 | 8.30 | 5.46 | 52.01 |
| Equity | 29.90 | 29.90 | 0.00 | 29.90 | 29.90 | 0.00 | 29.90 | 29.90 | 0.00 |
| PBIDTM(%) | 7.87 | 6.38 | 23.49 | 7.69 | 6.77 | 13.61 | 8.83 | 6.24 | 41.47 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: